Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Massachusetts Bill Raises Specter Of States Restricting Supplement Sales

This article was originally published in The Tan Sheet

Executive Summary

Massachusetts legislation casts too large a net in banning sale of weight loss and bodybuilding supplements to minors and moving the products behind the counter, say industry trade groups. The bill does not address removing adulterated products or affect online sales, but could point other states toward similar rules.

You may also be interested in...



Limiting Sport Supplement Sales To Minors Recommended By More Researchers

More than two-thirds of health food stores’ staff recommended creatine to researchers posing as teen athletes, results that researchers say should prompt pediatricians and retailers to educate young people on the risk of creatine and push states to ban sales of the substance to minors.

State Enforcement Needed On Weight Loss, Bodybuilding Supplements – Study

“The lax federal regulatory scheme for dietary supplements leaves extreme gaps in federal oversight that should be filled by state governments,” according to a report by public health experts. State attorneys general have “bully pulpit” to expand on enforcement authorities exercised by both FDA and FTC, they say.

C&D Expands Oral Care Portfolio, Acquires TheraBreath Mouthwash Brand In Latest Deal

Church & Dwight anticipates 15% growth for TheraBreath mouthwash brand in 2022 on larger sizes and wider distribution, especially outside US. It plans to acquire the firm for around $580m cash and close the deal before end of year

Topics

UsernamePublicRestriction

Register

PS107964

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel